Fearfrost - I'll have to get back to you on an opinion on BMRN, I've casually followed it through your board but I don't honestly know enough about it to offer an informed or useful opinion. I found a Biotech Stock Research BioMarin web interview I'm looking forward to listening to, it's from last August I think.
I'm usually pretty pessimistic when it comes to the overall market, and in the past I would sometimes switch over to a mostly cash mode, only to watch the markets keep climbing.
In particular I'm always worried about terrorist events in the U.S., sooner or later it's going to happen and may well have a terrible effect on the markets.
I lost a ton (like almost everyone) during the dot com implosion, and I'll do my damnedest to try and avoid that ever again, and it's little warning shots across the bow like last week that will be the first sign that a meltdown is perhaps starting again.
So the tremors from the world markets the past week have definitely concerned me, but since the majority of my investments are in stocks that aren't directly tied to the overall market sentiment, I'll probably stand pat on them for now.
I realize there's not any hard technical info in my views, I guess I go a lot by the gut and what I see around me in the news and hear on the street to form opinions on macro trends, and decide whether to act on them.
Macro event trading involves so many variables that are contradictory that it almost makes analyzing a single stock seem simplistic.
Almost... Aiming4.
I'm usually pretty pessimistic when it comes to the overall market, and in the past I would sometimes switch over to a mostly cash mode, only to watch the markets keep climbing.
In particular I'm always worried about terrorist events in the U.S., sooner or later it's going to happen and may well have a terrible effect on the markets.
I lost a ton (like almost everyone) during the dot com implosion, and I'll do my damnedest to try and avoid that ever again, and it's little warning shots across the bow like last week that will be the first sign that a meltdown is perhaps starting again.
So the tremors from the world markets the past week have definitely concerned me, but since the majority of my investments are in stocks that aren't directly tied to the overall market sentiment, I'll probably stand pat on them for now.
I realize there's not any hard technical info in my views, I guess I go a lot by the gut and what I see around me in the news and hear on the street to form opinions on macro trends, and decide whether to act on them.
Macro event trading involves so many variables that are contradictory that it almost makes analyzing a single stock seem simplistic.
Almost... Aiming4.
Recent BMRN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:53:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:50:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:48:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:34:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 05:42:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:48:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:43:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 12:30:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 11:55:45 PM
- BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics M • PR Newswire (US) • 03/12/2026 01:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2026 07:23:14 PM
- U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU) • PR Newswire (US) • 02/28/2026 01:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 01:49:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 01:39:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 01:31:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 01:28:58 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 06:59:04 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 05:30:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 03:18:05 PM
- BioMarin to Participate in Four Upcoming Investor Conferences in March • PR Newswire (US) • 02/24/2026 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 09:08:42 PM
- BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results • PR Newswire (US) • 02/23/2026 09:05:00 PM
- BioMarin to Host Fourth Quarter and Full-Year 2025 Financial Results Conference Call and Webcast on Monday, February 23, 2026, at 4:30pm ET • PR Newswire (US) • 02/17/2026 02:00:00 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2026 12:01:49 AM


